Supplier
Medical Center Pharmacy and Home Care Center, INC
Medical Center Pharmacy and Home Care Center, INC was paid $1.86M by Medicaid between Jan 2018 and Dec 2024, across 11 billing codes. Its largest line is J7503, Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg — 74% of everything it billed.
33Billing provider infoMEDICAL CENTER PHARMACY AND HOME CARE CENTER, INC
HAMDEN, CT 06514
HAMDEN, CT 06514
33aNPI1225482490assigned 04/14/2016
33bProvider typeDurable Medical Equipment & Medical Supplies
28Total paid$1.86M
24GClaims50,396
24DCodes billed11
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Durable Medical Equipment & Medical Supplies providers in Connecticut
Rank by total paid#25 of 310
Median peer was paid$31K
This provider vs. median61×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,976 | $93K | |
| 2019 | 5,273 | $179K | |
| 2020 | 8,200 | $264K | |
| 2021 | 9,143 | $292K | |
| 2022 | 8,520 | $336K | |
| 2023 | 8,703 | $389K | |
| 2024incomplete | 7,581 | $309K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7503 | Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg | 74% | 8,913 | 5,347 | $1.37M |
| J7507 | Tacrolimus, immediate release, oral, 1 mg | 7.6% | 5,498 | 3,732 | $141K |
| J7517 | Mycophenolate mofetil, oral, 250 mg | 6.4% | 6,187 | 5,283 | $119K |
| J7518 | Mycophenolic acid, oral, 180 mg | 6.3% | 2,351 | 1,856 | $118K |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | 2.2% | 7,856 | 7,494 | $40K |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | 1.5% | 12,285 | 6,391 | $28K |
| J8521 | Capecitabine, oral, 500 mg | 1.0% | 206 | 150 | $19K |
| S5000 | Prescription drug, generic | <1% | 249 | 195 | $13K |
| J7500 | Azathioprine, oral, 50 mg | <1% | 198 | 152 | $6K |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 6,640 | 5,532 | $6K |
| A4253 | Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips | <1% | 13 | 12 | $873.55 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBUKOWSKI, TERRI SUE (MANAGER, OUTPATIENT PHARMACY SERVIC)